{ "id": "RL33901", "type": "CRS Report", "typeId": "REPORT", "number": "RL33901", "active": false, "source": "University of North Texas Libraries Government Documents Department", "versions": [ { "source": "University of North Texas Libraries Government Documents Department", "sourceLink": "https://digital.library.unt.edu/ark:/67531/metadc807264/", "id": "RL33901_2010Jan06", "date": "2010-01-06", "retrieved": "2016-03-19T13:57:26", "title": "Follow-On Biologics: Intellectual Property and Innovation Issues", "summary": null, "type": "CRS Report", "typeId": "REPORT", "active": false, "formats": [ { "format": "PDF", "filename": "files/20100106_RL33901_ff9d6ea18bfbf8b34cf329892b8209bee0cfef5a.pdf" }, { "format": "HTML", "filename": "files/20100106_RL33901_ff9d6ea18bfbf8b34cf329892b8209bee0cfef5a.html" } ], "topics": [] }, { "source": "University of North Texas Libraries Government Documents Department", "sourceLink": "https://digital.library.unt.edu/ark:/67531/metadc806611/", "id": "RL33901_2009Nov02", "date": "2009-11-02", "retrieved": "2016-03-19T13:57:26", "title": "Follow-On Biologics: Intellectual Property and Innovation Issues", "summary": null, "type": "CRS Report", "typeId": "REPORT", "active": false, "formats": [ { "format": "PDF", "filename": "files/20091102_RL33901_110eaf98f50e423014e660361d596851720359cb.pdf" }, { "format": "HTML", "filename": "files/20091102_RL33901_110eaf98f50e423014e660361d596851720359cb.html" } ], "topics": [] }, { "source": "University of North Texas Libraries Government Documents Department", "sourceLink": "https://digital.library.unt.edu/ark:/67531/metadc689142/", "id": "RL33901_2009Aug03", "date": "2009-08-03", "retrieved": "2015-08-03T15:06:47", "title": "Follow-On Biologics: Intellectual Property and Innovation Issues", "summary": "This report reviews doctrinal and policy issues pertaining to follow-on biologics. The report first introduces the application of federal food and drug legislation to follow-on biologics. It next turns to the patent implications of marketing follow-on biologics. Following this review of substantive law, the remainder of the report introduces innovation policy issues pertaining to follow-on biologics.", "type": "CRS Report", "typeId": "REPORT", "active": false, "formats": [ { "format": "PDF", "filename": "files/20090803_RL33901_8e9a8a58df6a19c213b251256ad96e18458dcbd7.pdf" }, { "format": "HTML", "filename": "files/20090803_RL33901_8e9a8a58df6a19c213b251256ad96e18458dcbd7.html" } ], "topics": [ { "source": "LIV", "id": "Medicine", "name": "Medicine" }, { "source": "LIV", "id": "Drugs", "name": "Drugs" }, { "source": "LIV", "id": "Drug industry", "name": "Drug industry" }, { "source": "LIV", "id": "Intellectual property", "name": "Intellectual property" }, { "source": "LIV", "id": "Patents", "name": "Patents" } ] }, { "source": "University of North Texas Libraries Government Documents Department", "sourceLink": "https://digital.library.unt.edu/ark:/67531/metadc816813/", "id": "RL33901_2009Mar20", "date": "2009-03-20", "retrieved": "2016-03-19T13:57:26", "title": "Follow-On Biologics: Intellectual Property and Innovation Issues", "summary": null, "type": "CRS Report", "typeId": "REPORT", "active": false, "formats": [ { "format": "PDF", "filename": "files/20090320_RL33901_49f8d84cd8fa0f1023bba32e7d57cb210177e176.pdf" }, { "format": "HTML", "filename": "files/20090320_RL33901_49f8d84cd8fa0f1023bba32e7d57cb210177e176.html" } ], "topics": [] }, { "source": "University of North Texas Libraries Government Documents Department", "sourceLink": "https://digital.library.unt.edu/ark:/67531/metadc462669/", "id": "RL33901_2008Oct31", "date": "2008-10-31", "retrieved": "2014-12-05T09:57:41", "title": "Follow-On Biologics: Intellectual Property and Innovation Issues", "summary": "This report reviews doctrinal and policy issues pertaining to follow-on biologics. The report first introduces the application of federal food and drug legislation to follow-on biologics. It next turns to the patent implications of marketing follow-on biologics. Following this review of substantive law, the remainder of the report introduces innovation policy issues pertaining to follow-on biologics.", "type": "CRS Report", "typeId": "REPORT", "active": false, "formats": [ { "format": "PDF", "filename": "files/20081031_RL33901_d8d6e797ea67c97aa3d073f0aeb2edbfc3ae5876.pdf" }, { "format": "HTML", "filename": "files/20081031_RL33901_d8d6e797ea67c97aa3d073f0aeb2edbfc3ae5876.html" } ], "topics": [ { "source": "LIV", "id": "Intellectual property", "name": "Intellectual property" }, { "source": "LIV", "id": "Patent law and legislation", "name": "Patent law and legislation" }, { "source": "LIV", "id": "Copyright", "name": "Copyright" }, { "source": "LIV", "id": "Biomedical materials", "name": "Biomedical materials" }, { "source": "LIV", "id": "Biotechnology", "name": "Biotechnology" }, { "source": "LIV", "id": "Pharmaceutical research", "name": "Pharmaceutical research" } ] }, { "source": "University of North Texas Libraries Government Documents Department", "sourceLink": "https://digital.library.unt.edu/ark:/67531/metadc808247/", "id": "RL33901_2008May21", "date": "2008-05-21", "retrieved": "2016-03-19T13:57:26", "title": "Follow-On Biologics: Intellectual Property and Innovation Issues", "summary": null, "type": "CRS Report", "typeId": "REPORT", "active": false, "formats": [ { "format": "PDF", "filename": "files/20080521_RL33901_c872613ca7ec2d3981b542e919917db88138ebe5.pdf" }, { "format": "HTML", "filename": "files/20080521_RL33901_c872613ca7ec2d3981b542e919917db88138ebe5.html" } ], "topics": [] }, { "source": "University of North Texas Libraries Government Documents Department", "sourceLink": "https://digital.library.unt.edu/ark:/67531/metadc806296/", "id": "RL33901_2008Jan17", "date": "2008-01-17", "retrieved": "2016-03-19T13:57:26", "title": "Follow-On Biologics: Intellectual Property and Innovation Issues", "summary": null, "type": "CRS Report", "typeId": "REPORT", "active": false, "formats": [ { "format": "PDF", "filename": "files/20080117_RL33901_aa2c3d75b0df8d63e3ef576b83f4afaa9359877a.pdf" }, { "format": "HTML", "filename": "files/20080117_RL33901_aa2c3d75b0df8d63e3ef576b83f4afaa9359877a.html" } ], "topics": [] }, { "source": "University of North Texas Libraries Government Documents Department", "sourceLink": "https://digital.library.unt.edu/ark:/67531/metadc819918/", "id": "RL33901_2007Jun04", "date": "2007-06-04", "retrieved": "2016-03-19T13:57:26", "title": "Follow-On Biologics: Intellectual Property and Innovation Issues", "summary": null, "type": "CRS Report", "typeId": "REPORT", "active": false, "formats": [ { "format": "PDF", "filename": "files/20070604_RL33901_871d6e8fec0a2403ff78214226a5f563b7594752.pdf" }, { "format": "HTML", "filename": "files/20070604_RL33901_871d6e8fec0a2403ff78214226a5f563b7594752.html" } ], "topics": [] }, { "source": "University of North Texas Libraries Government Documents Department", "sourceLink": "https://digital.library.unt.edu/ark:/67531/metadc812892/", "id": "RL33901_2007Mar05", "date": "2007-03-05", "retrieved": "2016-03-19T13:57:26", "title": "Follow-On Biologics: Intellectual Property and Innovation Issues", "summary": null, "type": "CRS Report", "typeId": "REPORT", "active": false, "formats": [ { "format": "PDF", "filename": "files/20070305_RL33901_fded187bb180387d17e1b55bfba4d8d9b8f98d5f.pdf" }, { "format": "HTML", "filename": "files/20070305_RL33901_fded187bb180387d17e1b55bfba4d8d9b8f98d5f.html" } ], "topics": [] } ], "topics": [ "Economic Policy", "Health Policy", "Science and Technology Policy" ] }